Kendall Capital Management Cuts Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Kendall Capital Management trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 9.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,330 shares of the company’s stock after selling 235 shares during the quarter. Kendall Capital Management’s holdings in Cardinal Health were worth $276,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of CAH. Frazier Financial Advisors LLC boosted its holdings in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after acquiring an additional 104 shares during the last quarter. Promus Capital LLC purchased a new position in Cardinal Health during the 4th quarter worth $30,000. AM Squared Ltd purchased a new position in Cardinal Health during the 3rd quarter worth $33,000. Kentucky Trust Co purchased a new position in Cardinal Health during the 4th quarter worth $41,000. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after buying an additional 144 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on CAH shares. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a report on Tuesday, January 7th. Argus set a $148.00 price target on shares of Cardinal Health in a report on Tuesday, February 4th. Morgan Stanley boosted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. JPMorgan Chase & Co. boosted their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Trading Down 0.5 %

CAH stock opened at $126.40 on Monday. The company’s 50 day moving average is $125.58 and its 200 day moving average is $118.88. The stock has a market cap of $30.53 billion, a price-to-earnings ratio of 23.58, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $132.84.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.